14. Sept. 2026•3 Min. Lesezeit
Hanmi and Dongkook Lead Ibuprofen Cold Medicine Market; Chong Kun Dang and Dong‑A Join Competition This Fall
After the 2025 OTC standard change, Hanmi and Dongkook launched ibuprofen‑combination cold medicines last winter, and this fall Chong Kun Dang and Dong‑A are entering, expanding market competition.